Lundbeck image

Lundbeck buys Chelsea Therapeutics

May 12, 2014
Research and Development, Sales and Marketing Chelsea Therapeutics, Lundbeck

Lundbeck could pay as much as $658 million for neurological disorder specialist Chelsea Therapeutics as the firm looks to shore …

Riwal image

Clinical trials transparency: the journey so far

May 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, alltrials, rawal, transparency

There has been considerable publicity over the last year or two about transparency of information in clinical trials. However, activity …

christian_lebbink

Talentmark hires Benelux executive search head

May 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Talentmark, lebbink

Life sciences recruitment firm Talentmark has confirmed Christiaan Lebbink is to join the firm covering the Benelux and continental European region Lebbink, …

Merck image

Merck’s vorapaxar gains long-awaited FDA approval

May 9, 2014
Sales and Marketing Boehringer, FDA, Merck, lilly, vorapaxar, zontivity

Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …

astrazeneca_plaque

AstraZeneca begins lung cancer trial

May 9, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, MEDI4736, NSCLC, lung cancer

AstraZeneca, currently at the centre of a £63 billion bid from US giant Pfizer, has begun a late-stage trial of …

Wellcome Trust slams Pfizer/AstraZeneca bid

May 9, 2014
Medical Communications, Sales and Marketing GSK, Pfizer, Read, astrazenca, emms, merger, takeover

The UK’s largest and most respected medical research charity the Wellcome Trust has warned that Pfizer’s potential takeover of AstraZeneca …

Sun Pharma image

Latest Sun Pharma recall blow for firm

May 9, 2014
Manufacturing and Production Caraco, Cetirizine, Effexor, FDA, Sun Pharma, recall

India’s largest drugmaker Sun Pharmaceutical Industries is recalling almost 400,000 bottles of anti-depressant and antihistamine medications in the US, because …

screen_shot_2014-05-09_at_08

ABPI appoints manager 
from Pfizer


May 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pfizer, christine rowland

The ABPI has appointed Christine Rowland to the newly-created position of value and access manager for its commercial department.  Rowland …

NICE recommends Xtandi

May 9, 2014
Sales and Marketing Astellas, NICE, Xtandi, abiraterone, prostate

NICE has reiterated that Astellas Pharma’s Xtandi should be used to treat NHS prostate cancer patients – but has removed …

Avastin image

EU looks at eye drug allegations

May 8, 2014
Sales and Marketing EU, Lucentis, Novartis, Roche, avastin, offlabel

European Union regulators are considering whether they need to take any action over the recent allegations of anti-competitiveness involving Roche …

3d printing image

3D printed hearts ‘on the horizon’

May 8, 2014
Medical Communications, Sales and Marketing 3D, heart, louisville, printing, williams

The ‘inherent design flaws’ of the human heart could become a thing of the past as new 3D printing technology …

daniel_smith_high_res

Cobra Biologics appoints CSO


May 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CSO, cobra biologics, smith

Contract manufacturing organisation Cobra Biologics has hired Dr Daniel Smith as its chief scientific officer. Smith has spent the last …

NHS image

RPS: ‘Give pharma incentives’

May 8, 2014
Research and Development, Sales and Marketing NHS, RPS, rare diseases, royal pharmaceutical society

Incentives are urgently required to speed up the development of personalised medicines, according to a new report from the Royal …

screen_shot_2014-05-07_at_15

ICON appoints non-executive director

May 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICON, brady

Contract research organisation (CRO) ICON has appointed Dr Hugh Brady as a non-executive director.  Brady previously served as president at …

cancer image

Global cancer drug spend slows

May 7, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, IMS, spending

Spending on cancer drugs worldwide is slowing, according to a new report from the IMS Institute for Healthcare Informatics. The …

Bayer concludes $14bn Merck consumer care takeover

May 7, 2014
Sales and Marketing Bayer, Merck, OTC, consumer care, merger

 Bayer has confirmed its acquisition of US firm Merck’s over-the-counter (OTC) portfolio in a deal worth $14 billion. The arrangement …

US cancer docs warn of rising drug prices

May 7, 2014
Research and Development, Sales and Marketing ASCO, Cancer, NICE, Obama, US, United States, republicans

American cancer doctors are warning that the rising price of oncology medicines is making it unaffordable for the country’s healthcare …

screen_shot_2014-05-07_at_08

Triducive recruits senior account manager

May 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Triducive, hannagan

Comms consultancy firm Triducive has expanded with the appointment of a new senior account manager in Lucy Hannagan. Hannagan joins …

Pfizer will ‘suck AZ’s lifeblood’

May 7, 2014
Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, bbd, cable, merger

A former boss of AstraZeneca has warned that he fears Pfizer “will act like a praying mantis and suck the …

Ranbaxy image

Court stops Ranbaxy takeover

May 6, 2014
Manufacturing and Production, Sales and Marketing Ranbaxy, Sun Pharma, fad, manufacturing

An Indian court has stopped the sale of Ranbaxy Laboratories to Sun Pharmaceutical Industries after concerns were raised over insider …

The Gateway to Local Adoption Series

Latest content